Sperm Production in Atrophied Testicles

Testicular Atrophy and Spermatogenesis

Testicular atrophy is strongly associated with spermatogenic failure when accompanied by elevated FSH levels above 7.6 IU/L, according to the American Urological Association 1
An atrophied testicle typically has significantly reduced or absent sperm production, especially when associated with elevated FSH levels above 7.6 IU/L, which indicates spermatogenic failure, as reported by the European Association of Urology 1, 2, 3

Clinical Assessment of Atrophied Testicles

Physical examination should assess testicular size, consistency, and presence of any associated abnormalities such as varicoceles or epididymal abnormalities, as recommended by the American Urological Association 1, 2
Scrotal ultrasound can provide accurate testicular volume assessment, especially in cases where physical examination is difficult, according to the European Association of Urology 4
Hormonal evaluation, particularly FSH levels, helps determine the likelihood of sperm production - elevated FSH (>7.6 IU/L) with testicular atrophy strongly suggests spermatogenic failure, as stated by the American Urological Association 1, 3

Genetic Considerations in Testicular Atrophy

Karyotype testing is strongly recommended for males with severe oligospermia or non-obstructive azoospermia, as chromosomal abnormalities are more common in this population, according to the European Society of Human Reproduction and Embryology 5
Y-chromosome microdeletion testing should be offered to men with testicular atrophy and severe oligozoospermia or non-obstructive azoospermia, as recommended by the European Society of Human Reproduction and Embryology 5
Klinefelter syndrome (47,XXY) is the most common chromosomal abnormality associated with testicular atrophy and spermatogenic failure, as reported by the European Society of Human Reproduction and Embryology 5

Fertility Preservation Options

Microsurgical testicular sperm extraction (micro-TESE) may be considered for men with non-obstructive azoospermia to search for areas of preserved spermatogenesis, as recommended by the American Urological Association 6
Micro-TESE has been shown to be 1.5 times more successful than non-microsurgical testis sperm extraction in men with non-obstructive azoospermia, according to the American Urological Association 6

Long-term Monitoring

Men with testicular atrophy require monitoring for potential development of testicular cancer, as men with testicular atrophy may have a higher risk of malignancy, as reported by the European Association of Urology and the European Society for Medical Oncology 4, 7
Changes in the contralateral testicle, which may also be affected even in unilateral conditions, should be monitored, as recommended by the European Association of Urology 8

Testicular Atrophy Assessment and Management

Clinical Assessment

Testicular atrophy can be assessed through physical examination using a Prader orchidometer, which provides a good surrogate for volume measured via ultrasound in most cases 9
Scrotal ultrasound is indicated in selected cases where physical examination is difficult, such as with large hydrocele, inguinal testis, epididymal enlargement/fibrosis, thickened scrotal skin, or when the epididymis is large compared to the total testicular volume 9, 10
In cases of unilateral undescended testis, the contralateral normal descended testis may also have structural abnormalities, including smaller volume and softer consistency 9

Clinical Significance and Monitoring

Atrophic testes (<12 ml) are considered a risk factor for testicular cancer and should be monitored accordingly 11, 12
Men with testicular atrophy and testicular microcalcification (TM) should be offered testicular biopsy due to increased risk of testicular germ cell tumors 11
Men with atrophic testes should be advised to perform regular testicular self-examination for early detection of testicular cancer 11
Testicular biopsy should be considered for infertile men with atrophic testes (<12 ml) and testicular microcalcification 11
For adult men with a unilateral undescended testis and normal hormonal function/spermatogenesis, orchidectomy should be considered 11, 13

Testicular Atrophy and Semen Analysis

Relationship Between Testicular Volume and Semen Parameters

The assessment of combined ejaculate parameters, including concentration, motility, morphology, and total count, is more predictive of testicular function than any single parameter, according to the European Society of Human Reproduction and Embryology 14
Semen analysis evaluates multiple parameters that collectively reflect testicular production and sperm maturation, with the American Society for Reproductive Medicine recommending its use as a diagnostic tool 14

Clinical Implications of Testicular Atrophy

The semen abnormalities associated with testicular atrophy are typically consistent across multiple analyses, with the World Health Organization noting that a single semen analysis may not capture the full picture due to natural variability 14
Physical examination findings, including testicular size and consistency, are important for diagnosing testicular atrophy, with the European Association of Urology recommending the use of an orchidometer to measure testicular volume 14

Testicular Atrophy Diagnosis and Management

Hormonal Evaluation

The American Urological Association recommends measuring serum FSH and LH to distinguish between primary testicular dysfunction and secondary causes in patients with testicular atrophy 15, 16
Low or low-normal LH with low-normal testosterone suggests secondary hypogonadism from pituitary dysfunction, requiring prolactin measurement, according to the Endocrine Society 15, 16

Genetic Evaluation

The American Society for Reproductive Medicine recommends Y-chromosome microdeletion testing if sperm concentration is <1 million/mL or azoospermia is present, as chromosomal abnormalities occur in 10% of these patients 17, 18

Evaluate for Subclinical Conditions

Chronic medication use, such as opioids, corticosteroids, or anabolic steroids, can suppress the hypothalamic-pituitary-gonadal axis, leading to testicular atrophy, as reported by the American Urological Association 15, 16
Systemic diseases, including HIV/AIDS, diabetes, prior chemotherapy, or testicular radiation, can cause progressive testicular damage, according to the National Institute of Diabetes and Digestive and Kidney Diseases 15, 16

Avoiding Common Pitfalls

The American Urological Association advises against treating subclinical varicoceles found on ultrasound, as only palpable varicoceles improve fertility outcomes after repair 17

Testicular Atrophy and Fertility Implications

Clinical Significance and Cancer Risk

The European Urology guidelines suggest that testicular microcalcifications increase testicular cancer risk 18-fold in this population 19
History of cryptorchidism (undescended testicles) is the single most important risk factor to identify, and it substantially increases cancer risk, according to the European Urology guidelines 19
Men with testicular volume <12ml have a significantly increased risk of intratubular germ cell neoplasia (TIN) in the contralateral testis if testicular cancer develops, particularly if under age 30-40 years, as indicated by the European Urology guidelines 19

Diagnostic Evaluation and Fertility Preservation

The European Urology guidelines recommend assessing for testicular microcalcifications, which increase testicular cancer risk, using high-frequency probes (>10 MHz) to maximize resolution and accurate caliper placement 19
The American College of Radiology and Urology guidelines recommend repeat scrotal ultrasound with explicit attention to proper measurement technique using the Lambert formula (0.71 coefficient) to accurately assess testicular volume 19

Diagnostic Evaluation and Management of Testicular Atrophy

Introduction to Testicular Atrophy

The American Urological Association recommends measuring serum FSH, LH, and total testosterone on morning samples on at least two separate occasions for men with testicular atrophy, as hypogonadotropic hypogonadism is a common cause of testicular atrophy 20
Exogenous testosterone or anabolic steroid use can cause reversible testicular atrophy and azoospermia, and immediate discontinuation is recommended for men desiring fertility 20

Diagnostic Evaluation

The European Association of Urology recommends obtaining at least two semen analyses separated by 2-3 months for accurate diagnosis of testicular atrophy, as single analyses can be misleading due to natural variability 20
Testicular atrophy with elevated FSH typically presents with oligospermia or azoospermia, and sperm concentration below 5 million/mL mandates genetic testing 20

Treatment Approach

The American College of Radiology recommends human chorionic gonadotropin (hCG) injections as first-line treatment for restoring testosterone production and spermatogenesis in men with secondary hypogonadism 21
Testosterone replacement therapy is appropriate only if fertility is not desired, as exogenous testosterone will completely suppress remaining spermatogenesis 20

Fertility Preservation

The American Society for Reproductive Medicine recommends banking sperm immediately if any sperm are present in ejaculate, preferably 2-3 separate collections with 2-3 days abstinence between collections, to provide insurance against technical failures or poor post-thaw recovery 20
Avoiding exogenous testosterone or anabolic steroids is crucial to prevent further decline in fertility, as these can cause complete azoospermia through negative feedback 20

Testicular Atrophy and Scrotal Skin Appearance

Clinical Significance of Scrotal Changes

Scrotal wall thickening may occur with certain inflammatory conditions like epididymo-orchitis, which can contribute to testicular atrophy, as reported by the American College of Radiology 22, 23
Reactive hydrocele (fluid accumulation) can develop alongside testicular atrophy, further altering scrotal appearance, according to the American College of Radiology 22